The President & Chief Executive Officer of Aeterna Zentaris (NASDAQ: AEZS) is Buying Shares

By Carrie Williams

Today, the President & Chief Executive Officer of Aeterna Zentaris (AEZSResearch Report), Klaus Paulini, bought shares of AEZS for $11K.

Following this transaction Klaus Paulini’s holding in the company was increased by 50% to a total of $33K. Following Klaus Paulini’s last AEZS Buy transaction on August 13, 2020, the stock climbed by 0.6%.

See today’s analyst top recommended stocks >>

Based on Aeterna Zentaris’ latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $2.37 million and GAAP net loss of -$1,311,000. In comparison, last year the company earned revenue of $18K and had a GAAP net loss of $1.01 million. AEZS’s market cap is $133 million and the company has a P/E ratio of -7.80. The company has a one-year high of $3.62 and a one-year low of $0.29.

In the last 30 days, insiders have sold $33K worth of AEZS shares and purchased $11K worth of AEZS shares.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncology, endocrinology and women’s health. It operates through biopharmaceutical segment. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Charleston, SC.